Stockreport

POINT Biopharma Confirms No Supply Shortages Of 177Lu-PNT2002 For The SPLASH Trial [TheStreet.com]

POINT Biopharma Global Inc.  (PNT) 
PDF INDIANAPOLIS, May 05, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. ( ) (the "Company" or "POINT"), a company accelerating the discovery, development, and global [Read more]